Dindigul Farm Product Peer Comparison

BSE: 544201

₹14.00

₹0.00 (0.00%)

As on 31-Aug-2026IST

Market cap

₹34 Cr

Revenue (TTM)

₹62 Cr

P/E Ratio

9.2

P/B Ratio

1

Div. Yield

0 %

Edit

	Dindigul Farm Product	Hexagon Nutrition	Mukka Proteins	Sai Life Sciences	Marksans Pharma
Market cap (₹ Cr)	34	836	741	30,974	14,635
Revenue (₹ Cr)	62	325	1,768	2,250	3,172
Net Profit (₹ Cr)	-5.61	24.38	72.56	361.74	521.27
Net Margin (%)	-8.93	7.36	4.04	15.77	15.92
RoE (%)	-24.65	14.11	14.65	15.47	18.10
Price to Earnings	9.19	22.03	10.72	85.63	28.32
Price-To-Book	0.97	3.44	1.43	12.13	4.60

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Dindigul Farm Product	Hexagon Nutrition	Mukka Proteins	Sai Life Sciences	Marksans Pharma
Operating Revenue	62.05	324.93	1,006.42	1,694.57	2,622.85
Total Income	62.83	331.29	1,021.53	1,731.35	2,689.17
Total Expenditure	62.55	284.06	911.53	1,286.73	2,090.16
EBITDA	-0.51	40.87	94.88	407.84	532.68
Depreciation	1.87	8.77	13.55	138.57	83.39
EBIT	-2.37	32.10	81.33	269.27	449.30
Interest	2.89	3.95	37.25	78.34	11.66
Other Income	0.78	6.36	15.12	36.78	66.33
Exceptional Items	--	-0.80	--	--	--
Profit before Tax	-4.48	33.72	60.27	227.70	503.97
Provision for Tax	1.13	9.34	12.17	57.57	121.35
Profit after Tax	-5.61	24.38	48.10	170.13	382.62

Liabilities (₹ Cr)

	Dindigul Farm Product	Hexagon Nutrition	Mukka Proteins	Sai Life Sciences	Marksans Pharma
Shareholder's Funds	35.21	194.18	440.70	2,128.35	2,466.91
Minority Interest	--	--	15.80	--	22.47
Non-Current Liabilities	15.80	11.72	9.41	321.62	272.91
Current Liabilities	13.32	52.66	610.41	759.14	477.34
Total Liabilities	64.56	261.36	1,076.32	3,209.12	3,239.63

Assets (₹ Cr)

	Dindigul Farm Product	Hexagon Nutrition	Mukka Proteins	Sai Life Sciences	Marksans Pharma
Non-Current Assets	22.53	74.93	150.60	1,677.96	1,035.51
Current Assets	41.81	183.64	925.72	1,531.16	2,204.12
Total Assets	64.56	261.36	1,076.32	3,209.12	3,239.63
Total Debt*	17.92	26.60	450.29	128.64	23.09
Net Current Assets	28.49	130.98	315.32	772.02	1,726.78
Contingent Liabilities	--	86.98	116.73	58.11	--

Cashflow (₹ Cr)

	Dindigul Farm Product	Hexagon Nutrition	Mukka Proteins	Sai Life Sciences	Marksans Pharma
Cash From Operating Activities	-12.43	37.79	-111.93	314.05	206.66
Cash Flow from Investing Activities	-11.19	-22.69	-34.99	-536.67	-49.01
Cash from Financing Activities	23.61	-19.24	55.55	301.43	-65.15
Net Cash Inflow / Outflow	0.00	-4.13	-91.36	78.81	92.51

Ratios

Profitability Ratios

	Dindigul Farm Product	Hexagon Nutrition	Mukka Proteins	Sai Life Sciences	Marksans Pharma
ROCE (%)	-3.86	17.37	11.82	15.53	22.50
ROE (%)	-24.65	14.11	11.50	11.02	16.89
ROA (%)	-9.59	9.62	4.77	6.17	12.93
EBIT Margin (%)	0.45	14.53	10.93	26.24	22.84
Net Margin (%)	-8.93	7.36	4.71	9.83	14.23
Cash Profit Margin (%)	-6.04	10.20	6.01	18.20	16.97

Growth Ratios

	Dindigul Farm Product	Hexagon Nutrition	Mukka Proteins	Sai Life Sciences	Marksans Pharma
Revenue Growth (%)	-27.46	9.14	-27.06	15.66	20.46
EBIT Growth (%)	-97.87	50.38	-10.30	40.60	17.68
Net Profit Growth (%)	-164.22	99.58	-35.27	105.45	21.51
EPS Growth (%)	-147.27	99.59	-33.68	74.12	21.32
Book Value Growth (%)	240.67	11.19	11.26	120.22	19.46

Valuation Ratios

	Dindigul Farm Product	Hexagon Nutrition	Mukka Proteins	Sai Life Sciences	Marksans Pharma
Price / Earnings	0.00	0.00	21.12	93.36	26.48
Price / Book Value	1.64	0.00	2.23	7.48	4.08
Dividend Yield (%)	0.00	--	0.00	0.00	0.36
EV/EBITDA	274.16	0.63	12.63	34.97	15.68
Market Cap (₹ Cr)	57.83	0.00	980.95	15,882.87	10,075.92

Solvency Ratios

	Dindigul Farm Product	Hexagon Nutrition	Mukka Proteins	Sai Life Sciences	Marksans Pharma
Debt to Equity	0.51	0.14	1.02	0.06	0.01
Short term debt to equity ratio	0.04	0.08	1.01	0.06	0.01
Current Ratio	3.14	3.49	1.52	2.02	4.62
Quick Ratio	2.56	2.32	0.59	1.86	2.85
Interest Coverage	-0.55	9.54	2.62	3.91	44.22

Operating Efficiency Ratios

	Dindigul Farm Product	Hexagon Nutrition	Mukka Proteins	Sai Life Sciences	Marksans Pharma
Debtors to sales (%)	6.18	18.41	19.85	20.94	20.59
Asset Turnover	1.06	1.28	1.02	0.61	0.93
Receivable days	18.94	60.85	68.51	65.73	65.99
Inventory Days	65.45	78.96	175.65	22.19	97.24
Payable days	132.39	38.92	65.49	180.62	91.59
Cash Conversion Cycle	-47.99	100.89	178.67	-92.70	71.65

Annual
Quarterly